Works about SODIUM-glucose cotransporter 2 inhibitors

Results: 2187
    1
    2
    3
    4

    Capillary Ketone Level and Future Ketoacidosis Risk in Patients With Type 1 Diabetes Using Sodium–Glucose Cotransporter Inhibitors.

    Published in:
    Diabetes Care, 2025, v. 48, n. 6, p. 1016, doi. 10.2337/dc25-0125
    By:
    • Bapat, Priya;
    • Dhaliwal, Sharon;
    • Song, Cimon;
    • Zhang, Yucheng;
    • Scarr, Daniel;
    • Bakhsh, Abdulmohsen;
    • Budhram, Dalton;
    • Verhoeff, Natasha J.;
    • Weisman, Alanna;
    • Fralick, Michael;
    • Ivers, Noah M.;
    • Cherney, David Z.I.;
    • Tomlinson, George;
    • Mumford, Doug;
    • Lovblom, Leif Erik;
    • Perkins, Bruce A.
    Publication type:
    Article
    5
    6
    7
    8
    9

    Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2024 Clinical Practice Guideline.

    Published in:
    Annals of Internal Medicine, 2025, v. 178, n. 5, p. 705, doi. 10.7326/ANNALS-24-01926
    By:
    • Madero, Magdalena;
    • Levin, Adeera;
    • Ahmed, Sofia B.;
    • Carrero, Juan Jesus;
    • Foster, Bethany;
    • Francis, Anna;
    • Hall, Rasheeda K.;
    • Herrington, William G.;
    • Hill, Guy;
    • Inker, Lesley A.;
    • Kazancıoğlu, Rümeyza;
    • Lamb, Edmund;
    • Lin, Peter;
    • McIntyre, Natasha;
    • Morrow, Kelly;
    • Roberts, Glenda;
    • Sabanayagam, Dharshana;
    • Shlipak, Michael;
    • Shroff, Rukshana;
    • Tangri, Navdeep
    Publication type:
    Article
    10

    Use of Sodium‐Glucose Transport Protein 2 Inhibitors and the Incidence of Urolithiasis: A Multi‐Database and Cross‐Country Study in Patients With Type 2 Diabetes Mellitus.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 6, p. 1775, doi. 10.1002/cpt.3626
    By:
    • Chung, Mu‐Chi;
    • Lin, Chia‐Yen;
    • Chang, Chao‐Hsiang;
    • Chang, Yi‐Huei;
    • Hsiao, Po‐Jen;
    • Lien, Chi‐Shun;
    • Wu, Laing‐You;
    • Wu, Ming‐Ju;
    • Shieh, Jeng‐Jer;
    • Hung, Peir‐Haur;
    • Chen, Hsin‐Hua;
    • Chung, Chi‐Jung
    Publication type:
    Article
    11
    12
    13
    14

    The Impact of SGLT2 Inhibitors on Atrial Fibrillation Recurrence and Long‐Term Clinical Outcomes in HFrEF Patients Undergoing Cryoballoon Ablation: A New Frontier Beyond Diabetes and Heart Failure.

    Published in:
    Journal of Cardiovascular Electrophysiology, 2025, v. 36, n. 5, p. 952, doi. 10.1111/jce.16621
    By:
    • Cetin, Elif Hande Ozcan;
    • Cetin, Mehmet Serkan;
    • Könte, Hasan Can;
    • Ülvan, Nedret;
    • Çelik, Ezgi Merve;
    • Arslan, Koray;
    • Kocyigit, Duygu;
    • Korkmaz, Ahmet;
    • Ozcan, Fırat;
    • Ozeke, Ozcan;
    • Cay, Serkan;
    • Aras, Dursun;
    • Topaloglu, Serkan
    Publication type:
    Article
    15

    Expanding the Use of SGLT2 Inhibitors in T2D Patients Across Clinical Settings.

    Published in:
    Cells (2073-4409), 2025, v. 14, n. 9, p. 668, doi. 10.3390/cells14090668
    By:
    • Cuttone, Alessandro;
    • Cannavò, Vittorio;
    • Abdullah, Raouf Mastan Sheik;
    • Fugazzotto, Pierluigi;
    • Arena, Giada;
    • Brancati, Simona;
    • Muscarà, Andrea;
    • Morace, Carmela;
    • Quartarone, Cristina;
    • Ruggeri, Domenica;
    • Squadrito, Giovanni;
    • Russo, Giuseppina Tiziana
    Publication type:
    Article
    16
    17
    18
    19
    20

    SGLT2 inhibitors as a novel senotherapeutic approach.

    Published in:
    NPJ Aging, 2025, v. 11, n. 1, p. 1, doi. 10.1038/s41514-025-00227-y
    By:
    • Yesilyurt-Dirican, Zeynep Elif;
    • Qi, Ce;
    • Wang, Yi-Chian;
    • Simm, Annika;
    • Deelen, Laura;
    • Hafiz Abbas Gasim, Alia;
    • Lewis-McDougall, Fiona;
    • Ellison-Hughes, Georgina M.
    Publication type:
    Article
    21
    22
    23
    24
    25

    Water and electrolyte abnormalities in novel pharmacological agents for kidney disease and cancer.

    Published in:
    Clinical & Experimental Nephrology, 2025, v. 29, n. 5, p. 521, doi. 10.1007/s10157-025-02635-6
    By:
    • Terashita, Maho;
    • Yazawa, Masahiko;
    • Murakami, Naoka;
    • Nishiyama, Akira;
    • Fujimaru, Takuya;
    • Fujita, Yoshiro;
    • Hirose, Kazuhito;
    • Kawada, Kyogo;
    • Monkawa, Toshiaki;
    • Nagahama, Masahiko;
    • Ogata, Masatomo;
    • Ryuge, Akihiro;
    • Shibagaki, Yugo;
    • Shimizu, Hideaki;
    • Sumi, Hirofumi;
    • Tominaga, Naoto
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33

    Impact of baseline left ventricular ejection fraction and body mass index on the effect of 24-week Ipragliflozin treatment on left ventricular diastolic function in patients with type 2 diabetes and chronic kidney disease: insights from the PROCEED trial.

    Published in:
    Cardiovascular Diabetology, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12933-025-02745-1
    By:
    • Teragawa, Hiroki;
    • Tanaka, Atsushi;
    • Takahashi, Kanae;
    • Oshita, Chikage;
    • Uchimura, Yuko;
    • Kamei, Nozomu;
    • Hirai, Hiroyuki;
    • Shimabukuro, Michio;
    • Taguchi, Isao;
    • Okada, Yosuke;
    • Node, Koichi
    Publication type:
    Article
    34
    35

    Dapagliflozin, An SGLT2 Inhibitor, Improves Endothelial Cell Energy Metabolism Through Enhanced Mitochondrial Respiration.

    Published in:
    Cellular Physiology & Biochemistry (Cell Physiol Biochem Press GmbH & Co. KG), 2025, v. 59, n. 2, p. 235, doi. 10.33594/000000772
    By:
    • Walczak, Iga;
    • Braczko, Alicja;
    • Paterek, Aleksandra;
    • Rolski, Filip;
    • Urbanowicz, Krzysztof;
    • Tarnawska, Maria;
    • Knapczyk, Roksana;
    • Parzuchowska, Aleksandra;
    • Smoleński, Ryszard T.;
    • Hellmann, Marcin;
    • Mączewski, Michał;
    • Kutryb-Zając, Barbara
    Publication type:
    Article
    36

    Metformin for Type 2 diabetes mellitus.

    Published in:
    Academic Emergency Medicine, 2024, v. 31, n. 8, p. 832, doi. 10.1111/acem.14922
    By:
    • MacDonald, Blair J.;
    • Turgeon, Ricky D.;
    • McCormack, James
    Publication type:
    Article
    37
    38
    39
    40
    41

    Circulating level of β-aminoisobutyric acid (BAIBA), a novel myokine-like molecule, is inversely associated with fat mass in patients with heart failure.

    Published in:
    Heart & Vessels, 2024, v. 39, n. 1, p. 35, doi. 10.1007/s00380-023-02308-y
    By:
    • Katano, Satoshi;
    • Yano, Toshiyuki;
    • Kouzu, Hidemichi;
    • Nagaoka, Ryohei;
    • Numazawa, Ryo;
    • Yamano, Kotaro;
    • Fujisawa, Yusuke;
    • Ohori, Katsuhiko;
    • Nagano, Nobutaka;
    • Fujito, Takefumi;
    • Nishikawa, Ryo;
    • Ohwada, Wataru;
    • Katayose, Masaki;
    • Sato, Tatsuya;
    • Kuno, Atsushi;
    • Furuhashi, Masato
    Publication type:
    Article
    42
    43
    44
    45

    Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database.

    Published in:
    Acta Diabetologica, 2025, v. 62, n. 3, p. 343, doi. 10.1007/s00592-024-02359-1
    By:
    • Antonazzo, Ippazio Cosimo;
    • Rozza, Davide;
    • Cortesi, Paolo Angelo;
    • Fornari, Carla;
    • Zanzottera Ferrari, Elena;
    • Paris, Claire;
    • Eteve-Pitsaer, Caroline;
    • Gnesi, Marco;
    • Mele, Silvia;
    • D'Amelio, Marco;
    • Maurizi, Anna Rita;
    • Palladino, Pasquale;
    • Mantovani, Lorenzo Giovanni;
    • Mazzaglia, Giampiero
    Publication type:
    Article
    46
    47
    48
    49
    50